MicroRNA and heart failure

• Main Authors: Wong, L.L, Wang, J, Liew, O.W, Richards, A.M, Chen, Y.-T
• Other Authors: MEDICINE
• Format: Review
• Published: 2020
• Subjects: capadenoson; dicer; microRNA; microRNA 1; microRNA 100; microRNA 107; microRNA 122; microRNA 1246; microRNA 1254; microRNA 126; microRNA 133a; microRNA 133b; microRNA 142 3p; microRNA 15; microRNA 17; microRNA 17 5p; microRNA 183 3p; microRNA 18a; microRNA 195; microRNA 208a; microRNA 208b; microRNA 20a; microRNA 499; microRNA 92a; microRNA 92b; mineralocorticoid antagonist; myosin heavy chain alpha; neurohormone; spironolactone; unclassified drug; unindexed drug; hormone; apoptosis; biogenesis; clinical trial (topic); gene expression; gene targeting; heart arrhythmia; heart development; heart failure; heart hypertrophy; heart left ventricle ejection fraction; human; multicenter study (topic); nonhuman; phase 1 clinical trial (topic); phase 2 clinical trial (topic); Review; animal; genetics; metabolism; signal transduction; Animals; Heart Failure; Hormones; Humans; MicroRNAs; Signal Transduction
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/183342

10.3390/ijms17040502